Semma Therapeutics Headquarters
Looking for information about Semma Therapeutics Headquarters? The links below have collected all the necessary data.
Semma Therapeutics Company Profile - Office Locations ...
- https://craft.co/semma-therapeutics
- Semma Therapeutics headquarters is located at 100 Technology Square Floor 3, Cambridge. Where are Semma Therapeutics offices? Semma Therapeutics has an office in Cambridge .Founded: 2015
Semma Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/semma-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2015; Founders Douglas Melton, Felicia Pagliuca, Robert Millman; Operating Status Active; Last Funding Type Series B; Legal Name SEMMA THERAPEUTICS, INC. Company Type For Profit; Phone Number (857)529-6430Founded: 2015
Semma Therapeutics - Overview, News & Competitors ...
- https://www.zoominfo.com/c/semma-therapeutics-inc/372311697
- Semma Therapeutics’s headquarters are in 100 Technology Sq, Fl 3, Cambridge, Massachusetts, 02139, United States What is Semma Therapeutics’s phone number? Semma Therapeutics’s phone number is (857) 529-6430Employees: 62
Semma Therapeutics Company Profile: Acquisition ...
- https://pitchbook.com/profiles/company/110483-92
- Semma Therapeutics General Information Description. Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients.
Company Semma Therapeutics News, Employees and Funding ...
- https://www.topionetworks.com/companies/semma-therapeutics-55119e22b0494fdc55007245
- Semma Therapeutics. Location: Cambridge, MA. Add to My Lists. Share. Embed. Type 1 diabetes (T1D) is a chronic, life-threatening disease that affects millions of people worldwide. T1D is an autoimmune disease in which the patient’s immune system attacks and destroys pancreatic beta cells, which are responsible for regulating blood sugar levels by producing precise amounts of insulin.
Vertex to Acquire Semma Therapeutics With a Goal of ...
- https://investors.vrtx.com/news-releases/news-release-details/vertex-acquire-semma-therapeutics-goal-developing-curative-cell
- Sep 03, 2019 · BOSTON & CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Sep. 3, 2019-- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the company has entered into a definitive agreement under which Vertex will acquire Semma Therapeutics, a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for …
Vertex to Acquire Semma Therapeutics With a Goal of ...
- https://www.businesswire.com/news/home/20190903005227/en/Vertex-Acquire-Semma-Therapeutics-Goal-Developing-Curative
- Sep 03, 2019 · BOSTON & CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the company has entered into a definitive agreement under which Vertex will...Estimated Reading Time: 9 mins
Home Vertex Pharmaceuticals
- https://www.vrtx.com/
- Biotechnology to Create Transformative Medicines. At Vertex, we're relentless in our pursuit of medical research to create transformative medicines for people with serious and genetic diseases, like cystic fibrosis. Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Vertex to Acquire Semma Therapeutics With a Goal of ...
- https://news.vrtx.com/press-release/vertex-acquire-semma-therapeutics-goal-developing-curative-cell-based-treatments-type
- BOSTON & CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Sep. 3, 2019-- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the company has entered into a definitive agreement under which Vertex will acquire Semma Therapeutics, a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for …
Have you found Semma Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.